Antidepressant use during pregnancy
| Autor: | Ariela Frieder |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
medicine.medical_specialty
Pregnancy Fetus business.industry Persistent pulmonary hypertension Obstetrics and Gynecology Congenital malformations Serotonin reuptake medicine.disease Increased risk Reproductive Medicine Maternity and Midwifery Pediatrics Perinatology and Child Health medicine Antidepressant Intensive care medicine business Psychiatry Depression (differential diagnoses) |
| Zdroj: | Expert Review of Obstetrics & Gynecology. 6:285-294 |
| ISSN: | 1747-4116 1747-4108 |
| DOI: | 10.1586/eog.11.24 |
| Popis: | Depression during pregnancy affects 10–20% of pregnant women and can have detrimental effects (short and long term) for the mother, fetus and family. The use of antidepressants during pregnancy has been the subject of much debate. Recent data suggest a possible risk to the fetus with maternal use of antidepressants. Selective serotonin reuptake inhibitors have been associated with congenital malformations, negative pregnancy outcomes, neonatal behavioral symptoms and persistent pulmonary hypertension of the newborn. Women with depression tend to discontinue their medication when trying to conceive or upon discovering they are pregnant, placing themselves at increased risk of recurrence of their affective illness. Therefore, it is important for clinicians to understand the risks and benefits of antidepressant use during pregnancy in order to appropriately counsel women. The purpose of this article is to review updated information regarding the use of antidepressants during pregnancy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|